Safety/Efficacy Study of LDE225 (Sonidegib) Plus Bortezomib in Patients With Relapsed or Relapsed/Refractory Multiple Myeloma
Clinical trial NCT02254551 · TERMINATED
Trial details
- NCT number
- NCT02254551
- Sponsor
- SCRI Development Innovations, LLC
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-01-01
- Primary completion
- 2015-10-01
- Enrollment
- 7
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.